- Strong return on equity of 1,823.5%
- Highly efficient cash conversion (101% FCF/OCF ratio)
- Beat earnings estimates in 2 of the last 4 quarters
Red day on Monday for Quince Therapeutics, Inc. stock after losing 0.318%
(Updated on Jul 20, 2026)
The Quince Therapeutics, Inc. stock price fell by -0.318% on the last day (Monday, 20th Jul 2026) from $18.88 to $18.82. During the last trading day the stock fluctuated 5.99% from a day low at $18.29 to a day high of $19.39. The price has risen in 6 of the last 10 days and is up by 10.84% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -12 thousand shares and in total, 26 thousand shares were bought and sold for approximately $498.22 thousand.
Given the current short-term trend, the stock is expected to fall -34.86% during the next 3 months and, with a 90% probability hold a price between $9.62 and $12.26 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
QNCX Signals & Forecast
A buy signal was issued from a pivot bottom point on Wednesday, July 01, 2026, and so far it has risen 12.36%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Quince Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $18.91. On a fall, the stock will find some support from the short-term average at $18.43. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Quince Therapeutics, Inc. stock
Quince Therapeutics, Inc. finds support from accumulated volume at $18.19 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $1.10 between high and low, or 5.99%. For the last week the stock has had daily average volatility of 11.82%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (QNCX) For The Upcoming Trading Day Of Tuesday 21st
For the upcoming trading day on Tuesday, 21st we expect Quince Therapeutics, Inc. to open at $18.83, and during the day (based on 14 day Average True Range), to move between $18.05 and $19.59, which gives a possible trading interval of +/-$1.55 (+/-8.59%) up or down from last closing price. If Quince Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.59% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $18.19 (3.35%) than the resistance at $19.90 (5.72%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Quince Therapeutics, Inc. stock A Buy?
Quince Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score:
-1.625
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 21, 2026 - $18.83 ( 0.0620%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
QNCX Performance
Trading levels for QNCX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 19.93 | 5.88% |
| R2 | 19.51 | 3.66% |
| R1 | 19.25 | 2.28% |
| Price | 18.82 | |
| S1 | 18.41 | -2.16% |
| S2 | 18.15 | -3.53% |
| S3 | 17.74 | -5.76% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 22.00 | 16.90% |
| R2 | 21.40 | 13.71% |
| R1 | 19.90 | 5.72% |
| Price | 18.82 | |
| S1 | 18.19 | -3.35% |
| S2 | 17.25 | -8.34% |
| S3 | 16.75 | -11.00% |
FAQ
Click here for our free guide on how to buy Quince Therapeutics, Inc. Stock.
Buy QNCX